H-SER-ILE-LYS-VAL-ALA-VAL-OH(146439-94-3)
- Name: H-SER-ILE-LYS-VAL-ALA-VAL-OH
- Synonyms:1: PN: US20070020216 SEQID: 1 claimed protein;42: PN: WO2007035843 PAGE: 230 unclaimed sequence;2: PN: JP2008167695 SEQID: 4 unclaimed protein;3: PN: DE102015109599 PAGE: 7 claimed sequence;114: PN: US20100136614 SEQID: 115 unclaimed sequence;19: PN: WO2005095443 SEQID: 19 claimed protein;38: PN: WO2010033240 SEQID: 94 unclaimed sequence;26: PN: WO2010033220 SEQID: 94 unclaimed protein;16: PN: US7820172 SEQID: 16 claimed sequence;6: PN: US20030113478 SEQID: 6 claimed protein;76: PN: JP2007051127 SEQID: 72 unclaimed protein;L-Valine, N-[N-[N-[N2-(N-L-seryl-L-isoleucyl)-L-lysyl]-L-valyl]-L-alanyl]-;12: PN: CN102174575 PAGE: 10 unclaimed sequence;5: PN: WO2011036326 SEQID: 9 unclaimed protein;L-Seryl-L-isoleucyl-L-lysyl-L-valyl-L-alanyl-L-valine;17: PN: WO2010096572 SEQID: 3 unclaimed protein;4: PN: US20050063937 SEQID: 6 unclaimed sequence;6: PN: WO2007112048 PAGE: 30 unclaimed sequence;Hexapeptide-10;Serilesine;H-Ser-ile-lys-val-ala-val-OH;L-Valine,N-(N-(N-(N2-(N-L-seryl-L-isoleucyl)-L-lysyl)-L-valyl)-L-alanyl)-;L-Valine,L-seryl-L-isoleucyl-L-lysyl-L-valyl-L-alanyl-;
- Molecular Formula:C28H53N7O8
- Molecular Weight:615.76300
- CAS Registry Number:146439-94-3
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 146427-23-8/2-Pyrrolidinone, 4-[3-(cyclopentyloxy)-4-methoxyphenyl]-1-[(4-nitrophenyl)methyl]-, (R)-
- 146428-70-8/Copper(1+), (phosphine)-
- 146428-71-9/Copper(1+), bis(phosphine)-
- 146428-72-0/Copper(1+), tris(phosphine)-
- 146429-53-0/Carbamic acid, [2-[[3-[[2-chloro-5-[(1-oxohexadecyl)amino]phenyl]amino]-4,5-dihydro-5- oxo-1-(pentachlorophenyl)-1H-pyrazol-4-yl]thio]phenyl]-, phenylmethyl ester
- 14643-15-3/Sulfuric acid, monoethyl ester, yttrium(3+) salt, nonahydrate
- 146431-63-2/2-Pentanone, 5-pyrazinyl-
- 146431-73-4/Benzene, (1-bromo-3,3,3-trifluoro-1-propenyl)-, (Z)-
- 146431-94-9/2-Propenenitrile, 3-(1-azulenyl)-, (2E)-
- 146432-41-9/N,N-BIS(T-BUTYL-4-CARBOXYMETHYL)AMINOETHANOL
- 146432-43-1/DI-TERT-BUTYL-2-BROMOETHYLIMINODIACETATE
- 146434-24-4/8-Azabicyclo[3.2.1]oct-2-ene-8-propanenitrile, 7-cyano-4-oxo-
- 146434-35-7/Silane, (1-oxido-2,5-thiophenediyl)bis[trimethyl-
- 146436-27-3/Thiophene, 2-hexadecyl-5-methyl-
- 14643-82-4/1,3,2,4-Dioxathiazole, 5,5'-(1,8-octanediyl)bis-, 2,2'-dioxide
- 14643-83-5/1,4,2-Dioxazol-5-one, 3,3'-(1,2-ethenediyl)bis-, (E)-
- 146439-46-5/Propanedioic acid, (3-cyano-2-cyclopenten-1-yl)-, diethyl ester
- 146439-47-6/Propanedioic acid, (2-bromo-2-propenyl)(3-cyano-3-cyclopenten-1-yl)-, diethyl ester
- 146439-48-7/Bicyclo[3.2.1]octane-2,2-dicarboxylic acid, 6-cyano-4-methylene-, diethyl ester, endo-
- 146439-94-3/H-SER-ILE-LYS-VAL-ALA-VAL-OH
- 146443-11-0/Bicyclo[2.2.1]heptanedicarbonitrile
- 146443-63-2/Benzamide, N,N'-1,3-phenylenebis[4-methyl-
- 146444-57-7/L-Leucine, L-tyrosyl-L-glutaminyl-L-arginyl-
- 146444-58-8/L-Tyrosine, N-[N-[N-[N-[N-[N-[N-[N-[N-[N-(N-L-isoleucylglycyl)-L-tyrosyl]-L-isoleucyl]- L-tyrosyl]-L-tyrosyl]-L-seryl]glycyl]-L-seryl]-L-threonyl]-L-tyrosyl]-
- 146444-93-1/2H-Pyran, tetrahydro-2-[[5-(2-propenyloxy)pentyl]oxy]-
- 146446-05-1/2H-Pyran-2-one, 3-methyl-6-[(1E)-1-methyl-1-propenyl]-
- 146446-21-1/L-Serine, L-seryl-L-leucylglycyl-L-glutaminylglycyl-L-prolyl-L-a-glutamyl-L-phenylalan yl-L-leucyl-L-isoleucyl-L-tyrosyl-L-phenylalanyl-L-glutaminylglycyl-L-threonyl glycyl-L-alanyl-L-alanyl-L-a-aspartyl-L-a-aspartyl-
- 146446-85-7/L-Isoleucine, N-[(1,1-dimethylethoxy)carbonyl]-, phenylmethyl ester
- 146448-90-0/Phenanthrene, 1,3,6-trimethyl-
- 146448-91-1/Phenanthrene, 1,3,9-trimethyl-
